The Arivind Eye Care System treats 2.7 million patients a year in the developing world for blindness and other eye problems and seems to violate every rule of business. Patients pay what they want (if they pay at all, which most don't), it deliv-ers services for one percent of the cost of comparable care in developed countries, functions at many times the volume with a lower complication rate, and is com-pletely self-sustaining. This book is the first to tell its extraordinary story.
We use cookies and similar technologies to provide the best experience on our website.